Revefenacin is a long-acting muscarinic antagonist (LAMA) bronchodilator used as a once-daily nebulized treatment for maintenance therapy in chronic obstructive pulmonary disease (COPD). It features a labile primary amide that enables rapid systemic clearance, potentially minimizing systemic side effects.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 864750-70-9
Eluxadoline
pharmaceutical raw material
Сiprofloxacin hydrochloride
pharmaceutical raw material
Fostemsavir tromethamine
pharmaceutical raw material
Islatravir
pharmaceutical raw material
[1-[2-[[4-[(4-carbamoylpiperidin-1-yl)methyl]benzoyl]-methylamino]ethyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate
FYDWDCIFZSGNBU-UHFFFAOYSA-N
CN(CCN1CCC(CC1)OC(=O)NC2=CC=CC=C2C3=CC=CC=C3)C(=O)C4=CC=C(C=C4)CN5CCC(CC5)C(=O)N